news

 

Clifford Chance has advised the Hong Kong-listed SciClone Pharmaceuticals on an offer to take it private by healthcare-focused private equity firm GL Capital, with Slaughter and May acting for the buyer’s financial adviser, Capital Corporation Hong Kong Securities (CICC).

The transaction was implemented via a scheme of arrangement, which allows for a cash consideration of up to an approximate total of $1.13 billion.

Founded in 2010, GL Capital is an investment firm focusing on buyouts and growth opportunities in China’s healthcare industry.

SciClone is engaged in developing and commercialising a portfolio of marketed products as well as pipeline with potential in its focused therapeutic areas, including oncology and severe infection. The company was listed in Hong Kong in March 2021.

The Clifford Chance team was led by partners Christine Xu and Tommy Tam.

 Meanwhile, the Slaughter team was headed by partner Bonita Yu.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Appointments

Mumbai: CAM snaps up Trilegal banking pro

by Nimitt Dixit |

Indian law firm Trilegal has seen a rare recent partner departure, with banking expert Pranav Sharma rejoining Cyril Amarchand Mangaldas as an equity partner in Mumbai.

Features

ALB India Top PE/VC Boutique Firms 2024

by Asian Legal Business《亚洲法律杂志》 |

Emerging as pivotal players in India’s vibrant investment landscape, boutique private equity and venture capital law firms are gaining recognition for their significant role. These firms provide essential legal services and strategic counsel, supporting both investors and start-ups. Their expertise fosters innovation and economic growth, ensuring India remains a prominent force within the global start-up ecosystem. 

Appointments

PAG GC to join MoFo Tokyo as partner

by Asian Legal Business《亚洲法律杂志》 |

Morrison & Foerster is set to boost its private equity and M&A practices in Asia with the hire of veteran corporate lawyer Gregory Salathé as a partner in Tokyo. Salathé will join the firm in September from investment manager PAG, where he is currently a partner and group general counsel.